First do no harm: extending the debate on the provision of preventive tamoxifen - Wikidata - awgldk - TriplyDB

First do no harm: extending the debate on the provision of preventive tamoxifen

First do no harm: extending the debate on the provision of preventive tamoxifen

http://www.wikidata.org/entity/Q28365007

about

Validation of population-based disease simulation models: a review of concepts and methods The Population Health Model (POHEM): an overview of rationale, methods and applications CANADIAN CANCER RISK MANAGEMENT MODEL: EVALUATION OF CANCER CONTROL The evaluation of cancer control interventions in lung cancer using the Canadian Cancer Risk Management Model Uncertainty Analysis in Population-Based Disease Microsimulation Models

P2860

Q28744274-6249BB0C-AD2F-4D30-BB9A-A0B3F10BAFD0 Q36025063-175374B3-7B79-4270-94B2-2D6B6FF6B0A1 Q58287522-FF54F991-F0ED-4330-9DA1-A94B978408D1 Q58287526-9D691F28-E487-43C6-AC47-9BF923EF0937 Q58701365-45939E35-E4CA-431B-A227-360B141F7348

P2860

First do no harm: extending the debate on the provision of preventive tamoxifen

http://www.wikidata.org/entity/Q28365007

description

2001 nî lūn-bûn

@nan

2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2001 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2001年の論文

@ja

2001年論文

@yue

2001年論文

@zh-hant

2001年論文

@zh-hk

2001年論文

@zh-mo

2001年論文

@zh-tw

2001年论文

@wuu

name

First do no harm: extending the debate on the provision of preventive tamoxifen

@ast

First do no harm: extending the debate on the provision of preventive tamoxifen

@en

First do no harm: extending the debate on the provision of preventive tamoxifen

@nl

type

label

First do no harm: extending the debate on the provision of preventive tamoxifen

@ast

First do no harm: extending the debate on the provision of preventive tamoxifen

@en

First do no harm: extending the debate on the provision of preventive tamoxifen

@nl

prefLabel

First do no harm: extending the debate on the provision of preventive tamoxifen

@ast

First do no harm: extending the debate on the provision of preventive tamoxifen

@en

First do no harm: extending the debate on the provision of preventive tamoxifen

@nl

P1433

Q28365007-2594AC3C-AF2B-4164-B9A8-983F0CF551CB

P1476

Q28365007-D83CB6F2-4EF5-4636-97E8-D87C8A26C2C5

P2093

Q28365007-1350A7AD-28C1-4335-84D5-639DF055B748

Q28365007-29E45B00-6947-4053-8040-5B6D08D46068

Q28365007-7FC95F0D-C363-41CF-9AFB-13C5DD641A5A

Q28365007-815596E8-68D1-4280-8529-C30D8D2CB0A4

Q28365007-9B0E275E-6FBD-4C8B-9390-D27023BC7ED8

Q28365007-9C00A0C4-B5E4-4D08-9F86-9E737789CECB

Q28365007-E7AAD881-14B6-433F-A6C0-DA3554CA2C3A

P2860

Q28365007-0C0A91EC-9063-4F41-BD5C-790193CB7A6D

Q28365007-0F536039-BAD2-4E29-A85F-180DB5C2E66B

Q28365007-1323F4C6-6DB1-4F63-81A0-759B094E8651

Q28365007-2001E85E-6242-44E9-9EE5-A59A8DA7582D

Q28365007-278E4150-CC19-4B37-A4DE-EA90430985AB

Q28365007-2BA626B4-C0E5-453A-AF1E-423FA4371A48

Q28365007-4022450A-F426-494B-BFCF-B7E2199EEB58

Q28365007-461F8CAF-716C-43E9-9F64-72D469A265A5

Q28365007-50323067-23CE-45BC-9340-A76ADD6442AC

Q28365007-63926CE1-706E-46D6-A356-A42937FCCAAA

P2888

Q28365007-FA66BAD0-9350-418D-9480-4847AD081D9A

P304

Q28365007-85494094-FCB7-481C-9AB0-EFA68FF790CF

P31

Q28365007-0E4201DE-1614-46B5-BD26-9AB8C0B0C757

P356

Q28365007-93E74E84-B85F-4D17-B502-B19640C4442F

P407

Q28365007-B6AA10F3-FC6C-4B63-9F95-BE3E71E18AC0

P433

Q28365007-2156D5AC-2683-4041-A37F-9811F3ECAADD

P478

Q28365007-13135276-2FD2-4138-9C15-8B4A033534FE

P577

Q28365007-D2E708E6-7450-45D8-9263-F4DB5DAD205F

P5875

Q28365007-C5252B1D-D633-4E39-8B60-305B14056B73

P6179

Q28365007-0AADDCB2-667E-4704-B1CE-BE2C4FB36828

P698

Q28365007-5C5243AF-CA5E-4511-BDEE-FF25AFC158CE

P921

Q28365007-58B5610C-54BE-4E07-8C1A-D8210D22540C

P932

Q28365007-9650573F-A74A-4172-82BD-A2F35987B48B

P356

P1433

British Journal of Cancer

P1476

First do no harm: extending the debate on the provision of preventive tamoxifen

@en

P2093

B P Will

http://www.w3.org/2001/XMLSchema#string

D M Logan

http://www.w3.org/2001/XMLSchema#string

J M Berthelot

http://www.w3.org/2001/XMLSchema#string

K M Nobrega

http://www.w3.org/2001/XMLSchema#string

M C Wolfson

http://www.w3.org/2001/XMLSchema#string

W Flanagan

http://www.w3.org/2001/XMLSchema#string

W K Evans

http://www.w3.org/2001/XMLSchema#string

P2860

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Tamoxifen prevention of breast cancer: an instance of the fingerpost.

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer.

What makes clinical research ethical?

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen.

Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years

Using administrative data for longitudinal research: comparisons with primary data collection.

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.

P2888

P304

1280-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1054/BJOC.2001.2125

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P577

2001-11-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11635999

http://www.w3.org/2001/XMLSchema#string

P6179

1008481075

http://www.w3.org/2001/XMLSchema#string

P698

11720461

http://www.w3.org/2001/XMLSchema#string

P921

P932

2375241

http://www.w3.org/2001/XMLSchema#string